Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 103Other solid neoplasm 34Tumor-Agnostic 17Gastrointestinal 13Head & Neck 7Gynecologic 7Genitourinary 7Dermatologic 7Breast 7Sarcoma 5CNS 5Lymphoid 4Other neoplasm 1Other hematologic neoplasm 1Myeloid 1

Conditions

Pathological Conditions, Signs and Symptoms 1Pathologic Processes 1Neoplastic Processes 1Neoplasms 1

Interventions

Biopsy 4Cyclophosphamide 3Microarray Analysis 2Methylprednisolone 2Filgrastim 2Colposcopy 2Carboplatin 2toripalimab 1tipifarnib 1sargramostim 1sapanisertib 1pyroxamide 1pirfenidone 1penpulimab 1palbociclib 1liposomal doxorubicin 1iodixanol 1human papillomavirus vaccine, TA 1artemisinin 1arginine butyrate 1Zoledronic Acid 1Vincristine 1Video-Assisted Surgery 1Topotecan 1Tetradecanoylphorbol Acetate 1Taxes 1Tacrolimus 1Specimen Handling 1Sorafenib 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pemetrexed × Other neoplasm × Clear all
NCT00692159 2010-09-10

Study of TRC102 in Combination With Pemetrexed in Cancer Patients

Tracon Pharmaceuticals Inc.

Phase 1 Completed
28 enrolled
Other neoplasm

Neoplasms, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡